Whooping cough: A diagnosis one shouldn't forget;La coqueluche: Une maladie à ne pas oublier

Revue Medicale Suisse

Volumn 2, Issue 54, 2006, Pages 503-511

  Pósfay Barbe, Klara M ^a  

^a Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; VACCINE;

BORDETELLA PERTUSSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PATHOGENESIS; PERTUSSIS; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; RISK FACTOR; SEROLOGY; SYMPTOMATOLOGY; VACCINATION; ADOLESCENT; CASE REPORT; FEMALE;

ADOLESCENT; FEMALE; HUMANS; WHOOPING COUGH;

EID: 33747147864     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Wirsing von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002;2:744-50.
2. Guiso N, Bassinet L. Coqueluche-Whooping cough. EMC-Maladies Infectieuses, 2005;84-96.
3. Davis SF, Strebel PM, Cochi SL, Zell ER, Hadler SC. Pertussis surveillance-United States, 1989-1991. MMWR CDC Surveill Summ 1992;41:11-9.
4. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999;28 (Suppl. 2):S112-S7.
5. Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464-71.
6. OFSP. Déclarations dans le système de surveillance Sentinella: cas cliniques de coqueluche et recherche de Bordetella pertussis dans les frottis nasopharyngés par la méthode de PCR 1994-2003. Bulletin OFSP 2004;40: 746.
7. Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med 2005;142:832-5.
8. Rota MC, D'Ancona F, Massari M, et al. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Vaccine 2005;23:5299-305.
9. Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 1998;16:1761-7.
10. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003;290:2968-75.
11. Cherry JD. The epidemiology of pertussis: A comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005;115:1422-7.
12. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol 2005;43:2856-65.
13. van Amersfoorth SC, Schouls LM, van der Heide HG, et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 2005;43:2837-43.
14. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-7.
15. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005;24:761-5.
16. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: Who was the source? Pediatr Infect Dis J 2004;23:985-9.
17. Versteegh FG, Weverling GJ, Peeters MF, et al. Community-acquired pathogens associated with prolonged coughing in children: A prospective cohort study. Clin Microbiol Infect 2005;11:801-7.
18. Hewlett EL, Edwards KM. Clinical practice. Pertussis-not just for kids. Engl J Med 2005;352:1215-22.
19. Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995;21:1211-9.
20. Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: Results of a prospective multicenter surveillance study. Pediatrics 1997;100:E10.
21. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992; 14:708-19.
22. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ 2005; 172:509-15.
23. Heininger U, Kleemann WJ, Cherry JD. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004;114:e9-15.
24. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182:174-9.
25. Lievano FA, Reynolds MA, Waring AL, et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 2002; 40:2801-5.
26. Qin X, Turgeon DK, Ingersoll BP, et al. Bordetella pertussis PCR: Simultaneous targeting of signature sequences. Diagn Microbiol Infect Dis 2002;43:269-75.
27. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555-63.
28. Stehr K, Cherry JD, Heininger U, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 1998;101:1-11.
29. Committee on Infectious Diseases. Pertussis. In: Pickering L, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2003;472-86.
30. Wirsing von Konig CH, Postels-Mulani S, Bock HL. Schmitt HJ. Pertussis in adults: Frequency of transmission after household exposure. Lancet 1995;346:1326-9.
31. Grimprel E, Begue P, Anjak I, Njamkepo E, Francois P, Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diagn Lab Immunol 1996;3:93-7.
32. Guiso N, Grimprel E, Anjak I, Begue P. Western blot analysis of antibody responses of young infants to pertussis infection. Eur J Clin Microbiol Infect Dis 1993; 12:596-600.
33. Bass JW, Zacher LL. Do newborn infants have passive immunity to pertussis? Pediatr Infect Dis J 1989; 8:352-3.
34. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(5 Suppl.):S58-S61.
35. Hviid A, Stellfeld M, Wohlfahrt J, Andersen PH, Melbye M. The impact of pre-school booster vaccination of 4-6-year-old children on pertussis in 0-1-year-old children. Vaccine 2005, Pub (cf Med) sept 20.
36. Pichichero ME, Rennels MB, Edwards KM, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005;293:3003-11.
37. Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: Rationale and strategies for consideration. Vaccine 2001;20:641-6.
38. Greenberg DP. Pertussis in adolescents: Increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J 2005;24: 721-8.
39. Halperin SA, Smith B, Russell M, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000;18:1312-9.
40. Halperin SA. Pertussis - a disease and vaccine for all ages. N Engl J Med 2005;353:1615-7.
41. Casey JR, Pichichero ME. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs 2005;65:1367-89.
42. Hay JW, Ward JI. Economic considerations for pertussis booster vaccination in adolescents. Pediatr Infect Dis J 2005;24(6 Suppl.):S127-S33.
43. Forsyth K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global pertussis initiative international region: Recommended strategies and implementation considerations. Pediatr Infect Dis J 2005;24(5 Suppl.)S93-S7.
44. Forsyth KD, Campins-Marti M, Caro J, et al. New pertussis vaccination strategies beyond infancy: Recommendations by the global pertussis initiative. Clin Infect Dis 2004;39:1802-9.
45. Schellekens J, von Konig CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 2005;24(5 Suppl.): S19-S24.
46. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005;24 (5 Suppl.):S44-S7.
47. Cherry J, Heininger U. Pertussis and Other Bordetella Infections. In: Feigin R, Cherry JD, Demmler G, Kaplan S, editors. Textbook of Pediatric Infectious Diseases. Philadelphia: Saunders (Elsevier Science), 2004;1588-608.
48. Long S, Edwards K. Bordetella pertussis (Pertussis) and Other Species. In: Long S, Pickering L. Prober C. editors. Principles and Practice of Pediatric Infectious Diseases. Philadelphia: Churchill Livingstone, 2003;880-8.
49. Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001;139:380-4.
50. Office fédéral de la santé publique et Commission suisse pour les vaccinations. Plan de vaccination suisse 2005. http://www.bag.admin.ch/sichimpfen/impfplan/f/index.htm 2005;1-7.
51. Institut de veille sanitaire. Conseil supérieur d'hygiène publique de France. Calendrier vaccinal 2005. Bulletin épidé miologique hebdomadaire 2005;29-30:141-56.
52. Conseil supérieur d'hygiène. Calendrier vaccinal de base recommandé (2005-2006). 2005.
53. Santé et services sociaux Québec. Protocole d'immunisation du Québec. Chapitre 6, 2005.
54. Advisory Committee on Immunization Practices. Recommended Childhood and Adolescent Immunization Schedule (USA) · 2006. www.cispimmunize.org/ IZShedule_2006.pdf